Virtu Financial’s ENDRA Life Sciences NDRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,300
Closed -$16K 1873
2024
Q3
$16K Buy
+2,300
New +$178K ﹤0.01% 1148
2024
Q2
Sell
-20
Closed -$20K 1694
2024
Q1
$20K Buy
+20
New +$39.2K ﹤0.01% 1164
2022
Q3
Sell
-8
Closed -$65K 2046
2022
Q2
$65K Buy
+8
New +$71.5K 0.01% 1053
2022
Q1
Sell
-2
Closed -$50K 1837
2021
Q4
$50K Buy
+2
New +$84.9K 0.01% 1342
2020
Q4
Sell
-1
Closed -$31K 1672
2020
Q3
$31K Hold
1
0.01% 880
2020
Q2
$25K Buy
+1
New +$29K ﹤0.01% 1111
2019
Q4
Sell
-1
Closed -$30K 1706
2019
Q3
$30K Buy
+1
New +$53K ﹤0.01% 1256
2019
Q2
Sell
-1
Closed -$47K 1714
2019
Q1
$47K Buy
+1
New +$73K ﹤0.01% 1219
2018
Q4
Hold
0
1369
2018
Q3
Hold
0
1307

Other funds holding NDRA

Virtu Financial's NDRA Position: Q4 2024 in Review

Virtu Financial sold out of ENDRA Life Sciences (NDRA) in Q4 2024, closing a stake of 2,300 shares — an estimated $16K sold.

Virtu Financial first reported a position in NDRA in Q1 2019 and held it in 8 quarters. The position peaked at $65K in Q2 2022. 4 funds tracked by Wall St. Rank hold NDRA as of Q4 2024.

  • Virtu Financial reported no remaining ENDRA Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Virtu Financial sold 2,300 ENDRA Life Sciences shares in Q4 2024, an estimated $16K.
  • Virtu Financial first reported a position in ENDRA Life Sciences in Q1 2019 and held it in 8 quarters.
  • Virtu Financial's ENDRA Life Sciences position peaked at $65K in Q2 2022.
  • 4 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q4 2024.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.